Serves as Chief Executive Officer at AustinPx, bringing over two decades of expertise in the biotech and pharmaceutical sectors, formerly serving in leadership positions for West Pharmaceutical Services, Catalent, and Pii. Elizabeth holds a BA in Microbiology from The University of Texas at Austin and an MBA in Marketing from San Diego State University.
April 11, 2025
In the ever volatile, highly regulated precision medicine development sector, the agility and expertise of a CDMO can make or break a commercial drug candidate.
3 min read
November 26, 2024
How small molecule-focused CDMOs can help companies navigate the impact of the Inflation Reduction Act.
4 min read
November 22, 2017
Orally disintegrating tablets are winning patients over thanks to ease of use, but manufacture is unconventional, which raises a number of challenges and the need for careful consideration.
1 min read
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
